Tus kws kho mob
QP51-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2025
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 101 - 110 ntawm 3159
Tus kws kho mob
QP50-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Tus kws kho mob
QP49-25 MHCP Pharmacy Benefit Exclusion for Imaavy™, Lutrate Depot®, Tepylute, Ustekinumab and Ustekinumab-aekn
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Tus kws kho mob
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Tus kws kho mob
QP47-25 Updated Accessibility Requirements
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 11, 2025
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
Medicaid Reimbursement Policy Cellular and Gene Therapy Products
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
Commercial Reimbursement Policy Cellular and Gene Therapy Products
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.
Ntawv Thov Nyiaj Rov Qab thiab Kev Thov Kom Rov Txiav Txim Dua
Blue Cross and Blue Shield of Minnesota Self-Insured Complaint Form
Ntawv Thov Nyiaj Rov Qab thiab Kev Thov Kom Rov Txiav Txim Dua
BCBS Fully Insured Complaint Form